DNA is a remarkable, functional molecule that has evolved to encode and transmit information through multiple dimensions. The primary code stored within DNA comprises the four nucleobases adenine (A) , guanine (G), cytosine (C) and thymine (T) and it's the linear sequence of these four canonical bases that constitutes genetic information. Nature maintains, reads and transfers the genetic code through cognate base-pair recognition, a principle that was originally proposed by Watson and Crick 1 and involves A-T and G-C interactions (Figure 1 ). These interactions are also largely responsible for the double helical structure of double-stranded DNA. In fact, the primary DNA code can also be read from the major groove and minor groove of the DNA double helix. The major groove presents a distinct pattern of hydrogen bonds, giving rise to a 'major groove code', which reveals the specific sequence of base pairs and can be recognized and interpreted by proteins such as transcription factors [G]. 2 This enables the sequence-based activation of DNA functions, such as the transcription of a protein-coding gene to generate mRNA that is subsequently translated into protein. There is also a 'minor groove code', comprising base-pair specific hydrogen bonds in this groove that is narrower that then major groove. Although the major groove is predominantly read by proteins, it has been possible to read the primary sequence of DNA via synthetic polyamide molecules that bind to the minor groove. 3 5-methylcytosine (5mC) was probably the first variant of a canonical nucleobase to be discovered. 4 Since the discovery of 5mC in 1898 more than 17 modified DNA bases have been reported in the genomes of prokaryotes and eukaryotes, including mammals 5 ( Figure 2 ). A feature of these modifications is that they tend to not interfere with Watson-Crick pairing, but to introduce chemical functionality into the major groove of the double helix.
The introduction of added functionality in the major groove can certainly perturb or block protein recognition. This is applied in bacterial warfare whereby methylation of specific sequence sites in the host genome, called restriction methylation [G] , provides protection against self-cleavage by special nucleases. However, it is now recognized that site-specific modifications introduced into the major groove of DNA can recruit specific proteins (known as 'readers') that influence the function of the genome at that locus. Given that base modifications can be dynamically incorporated or removed by specific enzymes, it is possible that a sophisticated and reprogrammable major groove code may contribute to the regulation of the genome and all of its functions. Thus, the pattern of DNA base modifications may constitute an important layer of reprogrammable information in DNA, which is of particular interest in the genomes of higher organisms. In this Review we will discuss a number of classes of naturally occurring DNA modifications and explain how chemistry can be deployed to detect, map and decode these DNA base modifications in the genomic DNA of eukaryotes to elucidate their function.
Known modifications of DNA
The following sections gives an overview on eukaryotic DNA modifications, subdivided by their canonical base precursor.
Cytosine modifications.
The most studied DNA modification is cytosine methylation. It was discovered in 1898 4 and its existence was confirmed by Johnson and Coghill in 1925, who identified it as a hydrolysis product of tuberculinic acid. 6 In eukaryotes, methylation at the C5 position of cytosine is catalyzed by a class of enzymes known as DNA methyltransferases (DNMTs), which use Sadenosylmethionine (SAM) as the methyl donor. DNMT1 is mainly responsible for the maintenance of methylation marks during DNA replication, whereas DNMT3a and DNMT3b are involved in the methylation of new sites. 7, 8, 9 Recently, a new de novo DNA methyltransferase, DNMT3c, was discovered in rodent genomes, and it was shown to methylate the promoters
[G] of evolutionarily young retrotransposons in the male germ line. 10 In mammals, DNA methylation is involved in the maintenance of cellular functions and genomic stability, including processes such as X chromosome 15 Cytosine methylation predominantly occurs within the C-G dinucleotide (which is often referred to as cytosine-phosphate-guanine (CpG)) outside
CpG islands (CGI) [G]. 13 Recent studies, in which defined DNA sequences were inserted into the same locus of the genome, suggest that the overall base sequence composition influences DNA methylation and histone modifications at some CpGs but not at others. 16, 17 These studies support the view that the genome shapes its epigenome, although the mechanism underlying how sequence composition imparts methylation status is still not understood.
During early mammalian development, DNA methylation changes throughout the genome to direct pluripotent stem cells [G] to differentiate into distinct lineages that form various tissue types. Passive demethylation occurs when the DNA in newly replicated cells is not remethylated. DNMT1 is thought to exhibit a preference towards hemi-methylated sites over hemihydroxymethylated sites, thereby inhibiting 5mC maintenance 18 . Active DNA demethylation (that is, enzyme-mediated DNA demethylation) has also been observed, for example within the enhancer regions [G] of developmental genes during the phylotypic period (that is, during the development of the basic body shape) in organisms including mouse. 19 The active demethylation pathway involves the iterative oxidation of 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxycytosine (5caC) by the teneleven translocation (TET) enzymes (namely, TET1, TET2 and TET3), which are 2-oxoglutarate (2-OG) and Fe(II)-dependent dioxygenases. Subsequently, 5fC or 5caC is removed by base excision repair [G] (BER), which is mediated by the thymine DNA glycosylase (TDG), and replaced by unmodified cytosine (FIG. 3) . 20 The loss of function of enzymes, including TET and TDG, compromises the differentiation of mouse embryonic stem (mES) cells and is embryonically lethal in mice, illustrating that this DNA metabolism is vital to mammalian development. 21, 22 Although global levels of 5fC in mES cells (0.02% / dG, as measured by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) (See Box 2)) are lower than that of 5hmC, 5fC was found to occur at comparable levels to 5-hmC at specific genomic loci. 23, 24, 25 Recent developments that exploit chemistries for resolving DNA modifications, together with high-throughput (sometimes called 'next generation') sequencing approaches, have allowed the genome-wide mapping of 5hmC, 5fC and 5caC (see Box1 and Table 1 ). 5hmC, 5fC and 5caC are enriched in poised and active enhancers in ES cells and in mouse embryonic tissues. 26, 27, 28 Enhancers are distal regulating elements that initiate transcription by delivering protein complexes to promoters. Poised enhancers (that is, enhancers that are inactive but ready for activation) are flanked by bivalent histone marks (that is, histone modifications that combine the activating mark histone H3 lysine 4 monomethylation (H3K4me1) and the repressive mark histone H3 lysine 27 trimethylation (H3K27me3)), whereas active enhancers are marked by histone H3 lysine 27 acetylation (H3K27ac) and H3K4me1. Although oxidized cytosine derivatives were initially regarded as intermediates on the pathway to demethylation (FIG. 3) , it is emerging that they may function as epigenetic marks in their own right. Indeed, isotopic labeling experiments have shown that 5hmC and 5fC are largely stable in the genomic DNA of cultured cells and in vivo. 29, 30 Additionally, 5hmC, 5fC and 5caC-specific binding proteins have been identified from proteomics experiments that support roles for these cytosine modifications in chromatin remodeling and transcriptional regulation. 31, 32, 33 Another study found that double stranded 5fC-containing DNA could covalently interact with DNMT1; the bond formed between the 6C of 5fC and a catalytically essential cysteine residue of DNMT1 in vitro. 34 Since chromatin is key to all DNA-related processes (that is, replication, recombination, transcription, repair and chromosome segregation), it is essential to comprehend how DNA modifications effect the regulation and dynamics of chromatin structure to elucidate their biological function. Several groups have analysed the effect of cytosine modifications within CpG repeats on the stability of the DNA double helix. 35, 36 5mC and 5hmC, but not 5fC and 5caC, were found to stabilize the DNA duplex.
Additional biophysical experiments and X-ray crystallography on 5fC-containing oligonucleotides showed that 5fC can alter the structure of the DNA double helix through an extensive hydration network, suggesting that 5fC may be involved in chromatin remodeling by causing a change in DNA conformation. 36 In contrast to this work, a recent study 36b reported no significant alteration of the structure of DNA containing 5fC, which may reflect a capacity for 5fC-DNA to dynamically interconvert between structures.
Indeed, a recent molecular dynamics simulation study demonstrated that 5fC
and 5hmC enhance the flexibility of the DNA double helix, whereas 5mC
reduces DNA flexibility. 37 The increase in the flexibility of DNA caused by 5fC
and 5hmC increased the mechanical stability of nucleosomes (that is, the basic packaging unit of DNA in eukaryotes), indicating that these modifications may influence the dynamics of chromatin structure in vivo. particularly when it is present as U:G mispairs. 43 Although spontaneous hydrolytic deamination is slow, cytosine deamination can be driven enzymatically by the cytidine deaminases, activation-induced cytidine deaminase (AID) and apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC). They belong to the same family of enzymes, the cytidine deaminases, which is thought to have unique roles for generating specific genetic mutations and C-to-T transitions. 44 There is also some speculation that U may be an intermediate in the active demethylation of 5mC. 45 Indeed, AID is involved in a TET-independent active demethylation process at promoter regions. However, although AID can deaminate 5mC directly, alternative hypotheses suggest that the AID-driven deamination of C to U could initiate BER of 5mC containing sequences, leading to overall demethylation.
Eukaryotic DNA contains oxidised thymine derivatives, which are analogous in structure to those observed for cytosine modifications. 5-Hydroxymethyluridine (5hmU) and 5-formyluridine (5fU) occur at a level of 0.00001-0.0001%/dN in mammalian DNA. 46 Both modifications have been traditionally considered to be oxidative lesions caused by radical oxidation of thymine. Both 5hmU and 5fU can be excised by SMUG1 when base-paired with A 47 , yet they are repaired by several DNA glycosylases, including TDG and MBD4 when mispaired with G; the pairing of 5hmU and 5fU with G can occur as a consequence of deamination of the corresponding C-derivative. 48 As well as being the result of oxidative DNA damage, 5hmU may have a functional role in mammalian DNA. For example, some evidence suggests that 5hmU is an intermediate of active demethylation intermediate, formed
from the deamination of 5hmC by AID and APOBEC enzymes. However, whereas one study provided evidence to suggest that AID and APOBEC facilitated the deamination of hmC 49 , others found such enzymes had little ability to deaminate this modification in vitro 50 .
To determine the origin of T modifications in mammals, mES cells were grown in the presence of isotopically labeled thymine and methionine, and subsequently analysed by LC-MS/MS (Box 2). 46 Whereas all 5hmU and 5fU bases were found to be derived from isotopically labeled thymidine in wildtype cells, ~7% of 5hmU was found to be derived from 5hmC in cells in which TDG had been knocked down. This indicates that a 5hmC deamination pathway may occur, but that 5hmU resulting from this pathway is rapidly repaired.
Two independent groups have shown that 5hmU can be generated enzymatically from thymine oxidation 46, 51 by the TET family of oxidase enzymes. 5hmU levels correlated with TET expression, and subsequent differentiation studies showed that 5hmU appeared to form in processes that also lead to the production of 5hmC and 5fC. Proteomics studies have shown 5hmU to be recognized by chromatin remodeling proteins and transcription factors, suggesting a potential role for it in gene regulation. 46 T modifications are also prominently observed in the genomes of trypanosomatids [G]. 52, 53, 54 For instance, the hypermodified glucosylated thymine, β-D-glucosyl-hydroxymethyluracil, which is known as Base J ( 2 ). However, the methyl group rotates into the less-favoured trans position when in double stranded DNA, meaning that 6mA destabilizes DNA as compared to A due to the energetic penalty. 59 6mA in prokaryotes confers resistance against a host immune response as it cannot be broken down by host endonucleases; however 6mA can also modulate transcription in some bacteria. 60 6mA is also present in the genomes of simple eukaryotes, such as the green algae Chlamydomonas 61 , and there has been a resurgence of interest in 6mA owing to its identification in a number of higher eukaryotic organisms.
Specifically, 6mA has been identified in Caenorhabditis elegans (nematode worms) 62 , Drosophila melanogaster (fruit flies) 63 and mammals and vertebrates 64, 65 , where it is implicated in development.
Further study of 6mA in these species suggests that the role of this mark varies between organisms. 6mA in green algae (0.4% 6mA/dA) appeared to be associated with active gene expression and was found to be highly enriched in linker DNA, suggesting a role in nucleosome positioning 66 .
Work with C. elegans (0.3% 6mA/dA) indicates that epigenetic crosstalk occurs between 6mA and histone methylation, with evidence suggesting that the 6mA mark could be inherited across generations. 62 In D. melanogaster, 6mA levels were higher in early embryogenesis (0.07% 6mA/dA) to than at later stages of development (0.0001% 6mA/dA).
Furthermore, overexpressing an identified DNA 6mA demethylase (DMAD-1) in D. melanogaster was lethal to flies in early development, supporting a requirement for 6mA in genomic DNA during D. melanogaster development. 63 6mA was recently reported in vertebrates and mammals, albeit at low levels (0.00009% 6mA/dA in Xenopus laevis (frogs) 64 , ~0.0006% 6mA/dA in mouse 65 ). Work with mES cells found that the presence of 6mA led to transcriptional silencing. 65 Furthermore this study revealed that 6mA was mainly enriched on the X chromosome and a putative demethylase (ALKBH1) has been identified; knockdown of the gene encoding this protein in mES cells led to elevated levels of 6mA and the downregulation of >500 genes.
However, ALKBH1 is also known to function as a m1A demethylase 67 and 5-mC dioxygenase in transfer RNA [G] ,which might be important for regulating translational 68 , and it has also been shown to possess lyase activity at abasic sites 51 .
A link between 6mA and early embryogenesis was also demonstrated in zebrafish and pigs by LC-MS/MS, as 6mA were observed to reach levels as high as 0.1% 6mA/dA in early embryonic stages, before being drastically reduced. 69 This highlights a potential role for 6mA in early mammalian development, which is in line with a role for 6mA in the development of D.
melanogaster.
It should be noted that one LCMS/MS study could not replicate the levels of 6mA observed by others in mESC and mouse tissues, cautioning that the presence of 6mA in other studies may have arisen as an artifact due to bacterial contamination. 70 This has raised questions over the potential relevance of 6mA in mammalian DNA, and further work is needed to confirm such studies. The study doesn't explore early embryonic samples in which 6mA levels are reported to be substantially higher.
Over the recent years it has become apparent that eukaryotic genomes contain various DNA modifications. Technical advances have allowed us to detect, quantify and determine their genomic loci. The chemistry associated with these technologies is discussed in the next section.
Chemistry-based sequencing methods
Chemistry has played a central role in the development of innovative tools that contribute to the understanding of the function of modified DNA bases. Herein, we focus on chemical approaches for the detection, mapping and sequencing of modified DNA bases in the genomes of various organisms (TABLE 1) . 71 General sequencing approaches to detect modified bases. Detecting modified bases at single-base resolution using bisulfite.
To determine the presence of a modified base at single-base resolution, methods that cause a selective chemical transformation that alters the Watson-Crick base-pairing pattern, such as the bisulfite reaction, can be broadly applied to established sequencing platforms. The bisulfite reaction, which decodes the cytosine modification 5mC, catalyses the hydrolytic deamination of cytosine to uracil, whilst 5mC remains resistant to deamination (FIG. 4) . 74 Since U has the same base-pairing properties as T, the resultant U base pairs with A rather than G. The bisulfite-mediated conversion of DNA followed by sequencing, which is referred to as bisulfite-sequencing (BS-seq),
creates a global genome-wide map at single-base resolution on which C and 5mC can be distinguished. A drawback of BS-seq is that it cannot distinguish between 5mC and 5hmC, since both are resistant to deamination 75 and cytosine, 5fC and 5caC all convert to uracil under bisulfite conditions.
Chemical and enzymatic methods have been developed to distinguish 5hmC from 5mC (FIG. 4 and TABLE 1 ). Oxidative bisulfite sequencing (oxBS-seq) 76 uses potassium perruthenate (KRuO4) to first selectively oxidize 5hmC to 5fC, which deaminates to uracil along with C and 5caC during subsequent bisulfite treatment. This means that, in oxBS-seq, only 5mC is read as "C", giving a direct readout of this C modification. Subtracting an oxBS-seq dataset from a BS-seq dataset of the same DNA sample can reveal the presence of 5hmC at single base resolution.
Chemo-enzymatic TET-assisted bisulfite sequencing (TAB-seq) 77 provides another method to resolve 5mC and 5hmC at single-base resolution. 5hmC is first protected by glucosylation using a T4 β-glucosyltransferase (β-GT).
Recombinant mouse TET1 (mTET1) is then used for the iterative oxidation of 5mC to 5caC, which deaminates to uracil during subsequent bisulfite treatment. As glucosylated 5hmC is the only remaining C-derivative that does not deaminate, TAB-seq can give a direct readout of 5hmC. Subtracting a TAB-seq dataset from a BS-seq dataset for the same DNA sample reveals where 5mC is present in the genome at single base resolution.
Other methods have since been developed for the sequencing of modified C bases (FIG. 4 and TABLE1) . 71 Reductive bisulfite sequencing (redBS-seq), for example, uses NaBH4 to reduce 5fC to 5hmC. 24 Similar to the procedure for oxBS-seq, subtraction of the redBS-seq dataset from a BS-seq dataset allows the single base resolution sequencing of 5fC. Another bisulfite-based method exploits the use of chemical treatment with EtONH2, which protects 5fC from bisulfite-mediated deamination; this method is called 5fC chemically assisted bisulfite sequencing. (fCAB-seq) 78 . Comparing the fCAB-seq dataset with the BS-seq dataset allows the genomic location of 5fC to be determined at single base resolution.
While bisulfite based sequencing is regarded as the 'gold standard' for the analysis of C modifications, it has serious deficiencies. 80 and post-bisulfite adaptor tagging (PBAT) 81 . These methods result in increased uniformity of coverage and an adapted version of the latter technique is now the standard method for analyzing DNA methylation in single cells. 82 In this adaptation of PBAT, bisulfite conversion is performed on single cells prior to five rounds of random priming to tag and amplify the material.
Bisulfite-free techniques to detect modified bases at single-base resolution
Bisulfite-free base resolution sequencing methods have recently been developed that enable C-to-T transitions during PCR. One such technique takes advantage of the conversion of hmC to trihydroxylated thymine using peroxotungstate 83 , whereas another, 5fC cyclization-enabled C-to-T transition (fC-CET) sequencing, selectively targets 5fC using derivatives of 1,3-indianone 84 (FIG. 4 and TABLE 1 ).
Modified bases can also be detected at single-base resolution, without any prior chemical transformation, using SMRT-seq. 85 In this single-molecule sequencing technology, fluorescent nucleosides, each of which has a unique kinetic signature, are inserted opposite the template strand by a processing polymerase. Modified bases in the template strand can be differentiated from canonical bases as the polymerase has a greater tendency to pause in the presence of a modification. Chemical labeling is commonly used in combination with SMRT-seq to improve signal detection, as bulkier modified bases are easier to distinguish from canonical bases. 86 Simultaneous mapping of 5hmC, 5fC and 5caC was achieved using chemical labeling and
SMRT-seq at near single base resolution in a fungal model system. 87 92 and we anticipate that nanopore sequencing instruments may be used more routinely in the future.
DNA modifications in disease and therapy
It is emerging that DNA modifications not only play fundamental roles during normal development, but also may contribute to disease progression.
Ultimately, understanding and control over these processes may lead to novel therapeutic approaches as outlined in the next section.
DNA base modifications in disease.
The epigenetic profile of a genome reflects its cellular state and can reflect the identity of the cell or tissue. In an evolving cancer genome, the epigenetic state of DNA bases is thought to influence the mutational changes that occur, such that the mutation rate variation is linked to the epigenomic features of the cell of origin. 95, 96, 97 Two independent studies have reported, for example, that 5mC is more likely than 5hmC to undergo C-to-T changes in the context of CpG in human malignancies. 98, 99 Also, in disease states, epigenetic marks can become aberrant and methods to detect such changes have the potential to detect, diagnose and monitor disease. For example, atypical methylation patterns at specific CpG islands and in tumor suppressor genes is a hallmark of cancer. 100, 101, 102 In addition, certain genes are hypermethylated in a number of neurodegenerative disorders, including Alzheimer's disease. 103 A global reduction in 5hmC levels has been observed in many cancers. This reduction may arise from mutations that result in dysfunctional TET proteins; the increased production of the TET inhibiting metabolite 2-hydroxygluturate, which can be caused by mutations in the genes encoding enzymes such as isocitrate dehydrogenase (IDH)); or the silencing of TET proteins as a result of methylation of the genes that encode them. 104, 105, 106, 98 Alternatively, TETmediated 5hmC simply may not be maintained in cancerous tissue as there is a correlation between 5hmC levels and cell proliferation, i. e. 5hmC is passively diluted out of the genome. 29 Although global epigenetic changes might be indicative of disease, clinical case studies that identify specific epigenetic changes that mark, or more preferably indicate the cause of, the disease state may lead to clinical tests. Indeed, a 5mC based diagnostic test was recently approved for the non-invasive detection of colorectal cancer, which paves the way for other epigenetics-based diagnostic tests in the future. 107 Also routinely used in the diagnosis of glioblastoma is a test that measures the level of methylation at the promoter of the O6-methylguanine-DNA methyltransferase (MGMT) gene. MGMT is involved in the repair of alkylating agent-induced damage in DNA and methylation of the MGMT promoter decreases the expression of MGMT protein and, therefore, potentially increases the sensitivity of patients with glioblastoma to therapy. 108 There is also a potential link between T modifications and disease in mammalian systems. 5fU is a known mutagen in mammalian tissue, likely due to its propensity to mispair with guanine in DNA 109 , and elevated blood levels of 5hmU have been linked with breast and renal cancer. 110, 111 Levels of uracil are reported to be elevated in cancerous tissue, and enzymatic deamination that is mediated by AID and APOBEC is thought to cause C-to-T transitions in tumour suppressor genes or oncogenes and to be linked with the onset of disease. 112 These cytidine deaminases are overexpressed in certain cancers, although there is currently some debate as to whether the mutations they cause are derived from the deamination of cytosine, or of 5mC, or of both. 113 AID overexpression is associated with global demethylation, with mutational biases located at CpG sites, although AID enzymes demonstrate greater activity towards unmethylated cytosine in vitro. 50 
Therapeutic approaches for targeting DNA base modifications in disease.
Due to the link between aberrant epigenetic regulation and disease, it is attractive to consider therapeutics that can reprogramme the epigenome of cells towards a non-disease state. Inhibitors of DNA methylation can reduce methylation and increase the expression of certain genes in disease states.
For example, the ribo-and deoxyribonucleoside analogues of 5-azacytidine are currently used in the clinic to treat cancer including leukemia. 114 that have been tethered with DNA modifiers such as DNMT and TET have also been shown to specifically alter gene expression, highlighting a potential approach for future therapy. 117, 118 There are also opportunities to develop epigenetic therapies that target the unique regulatory system used in trypanosomatids. Inhibitors could be developed to specifically target JBP or JGT enzymes; targeting these enzymes would globally deplete Base J, which affects transcriptional regulation in these systems. Such therapeutics could be useful to treat a host of tropical diseases that are associated with trypanosomatids, such as Leishmaniasis and African sleeping sickness, 119 potentially without sideeffects as these enzymes are absent in humans.
Concluding remarks and future outlook
The discovery and subsequent insights gained into oxidised cytosine modifications in the human genome has stimulated considerable interest in the chemical modification of nucleotides. The discovery of 5hmC in mammalian DNA was partly inspired by knowledge of the homology between JBP enzymes in trypanosomatids and the mammalian TET enzymes. 120, 121 The growing knowledge of known DNA base modifications and the huge expansion in our knowledge of genomes and genome function provides information and inspiration for other exciting discoveries in due course.
State-of-the-art chemical analysis techniques, such as LC-MS/MS, now allows the abundance and formation of relatively rare base modifications, such as 5hmU, to be identified as veritable DNA modifications rather than ubiquitous damage in mammals. In the future, the sensitivity of such methods will improve and will enable us to uncover more about other chemical The gold-standard of mass quantification employs an internal standard that is isotopically labelled (SIL) to enable robust and accurate quantitation of DNA modifications typically at femtomole quantities. 128 (see the figure, part b). Ideally the SIL has chromatographic and ionisation properties that are virtually the same as the non-labelled analyte but a different mass signal that can be integrated separately (for example, 13 CD3 is used to label 5mC; 15 N3 is used to measure dC, note 13 C and 15 N isotopes are annotated with blue
asterisks) The amount of isotope-labeled internal standard is added to the calibration line and to each digested sample in equal amounts. The area ratio between the labeled and non-labeled base can then be used for improved precision in the quantificationThe SIL standard and analyte itself will co-elute, correcting for matrix effects, and will also account for variation in injection volume or ion suppression.
Modern-day mass spectrometers can accurately quantify over a wide-range of concentrations and are sensitive enough to detect femtomol (fmol) levels of (modified) nucleosides. 46 Mass signals can be improved by HPLC or affinity pre-enrichment (for example, biotin can be used to concentrate sample by affinity enrichment prior to injection of large quantities of digested DNA prior to LC-MS/MS injection 52, 23 , or via the prior chemical derivatization of modified bases with a MS sensitizer tag containing for example a quartenary nitrogen. 129 This has been applied for the detection of low abundance modifications (< 0.001% of bases) such as 5fC 23 and 5fU 129 1) The first report on the double helical structure of DNA and the pairing of G-C and A-T bases. This work provides the first genome-wide map of 5fC in embryonic stem cell demonstrating that the 5fC pattern was TDG-dependent.
